Mirapex and Emgality drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirapex (pramipexole dihydrochloride) and Emgality (galcanezumab-gnlm). Common drug interactions include drug ineffective among females.

The phase IV clinical study analyzes what interactions people have when they take Mirapex and Emgality. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Mirapex?

Mirapex has active ingredients of pramipexole dihydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 20,622 Mirapex users. Check the latest studies of Mirapex.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

On Jul, 15, 2026

11 people who take Mirapex and Emgality together, and have interactions are studied.

What are the common drug interactions of Mirapex and Emgality, by gender? *:

female:

Drug ineffective
Alopecia (absence of hair from areas of the body)
Hip fracture
Ligament rupture (tear in ligament)
Migraine (headache)
Pulmonary embolism (blockage of the main artery of the lung)
Stress fracture (fracture of a bone caused by repeated (rather than sudden) mechanical stress)
Weight bearing difficulty (difficulty due to weight of thigh fat deposition)
Back pain
Blindness

male:

n/a

What are the common drug interactions of Mirapex and Emgality, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Blindness
Corneal infection (corneal infection)
Corneal perforation (small hole in a cornea)
Corneal scar (nullah)
Corneal thinning
Eye swelling
Ulcerative keratitis (ulcerative inflammation of the cornea)

50-59:

Alopecia (absence of hair from areas of the body)
Pain
Ill-defined disorder
Pulmonary oedema (fluid accumulation in the lungs)
Pyrexia (fever)
Upper respiratory tract infection
Urinary tract infection
Viral upper respiratory tract infection
Drug ineffective
Fatigue (feeling of tiredness)

60+:

n/a

What are the existing conditions these people have? *

Migraine (headache): 4 people, 36.36%
Asthma: 2 people, 18.18%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 18.18%
Immunodeficiency: 2 people, 18.18%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 1 person, 9.09%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 1 person, 9.09%
Bladder Pain: 1 person, 9.09%
Bone Loss: 1 person, 9.09%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 9.09%
Cystitis Interstitial (unknown cause characterized by bladder pain): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Mirapex and Emgality?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously